Thomas Ybert

Thomas Ybert, CEO of DNA Script

Thomas Ybert, PhD is the co-Founder and CEO of DNA Script, a leading DNA synthesis company with a vision of engineering biology to accelerate breakthroughs in life science. After obtaining an engineering degree and a Ph.D. in biotechnology from Ecole Polytechnique (Paris, France), Ybert joined Sanofi, where he developed a biotherapeutic production platform for oncology based on yeast technologies. He subsequently joined the New Energies division of the French oil and gas giant Total, where he contributed to the establishment of the bio-fuel collaboration with Amyris. As the first Total employee to join Amyris in San Francisco, Ybert led the development of novel metabolic routes for bio-fuel and specialty chemicals. Upon his return to France, he established DNA Script, for which he spent the first two years at Institut Pasteur developing the technological foundation for the company’s Enzymatic DNA Synthesis (EDS) process. In 2014, he founded the San Francisco and Paris-based company DNA Script, to tackle one of the major challenges in life sciences: being able to write DNA as fast and as simple as reading DNA.

Listen to the interview with Thomas (published November 2021)


New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup